Ionis Pharma (IONS) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Ionis Pharmaceuticals (IONS) PT Raised to $57 at Stifel
February 28, 2018 6:39 AM ESTStifel raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $57.00 (from $55.00) while maintaining a Hold rating.
Analyst Stephen Willey notes SPINRAZA royalties highlight increasing leverage, with IONIS-HTTRx data now on deck.
... More
